Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
This comparison highlights retirement index funds with the smallest fees, helping you choose cost-efficient options for a brighter retirement.
27,211 articlesImmunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Inflation is pushing shoppers to hunt for value, and Target is answering with a broad price-cut program on 3,000 item...
Palantir has a large revenue backlog, a major Army contract on the books, and ambitious growth guidance. This analysi...
AST SpaceMobile has surged, leaving investors asking whether spacemobile buy, sell, hold makes sense now. This articl...
Disney stock has pulled back in 2026, raising the big question for investors: should disney stock? be part of a longe...
Palantir surged into focus after blowout Q1 results and a fresh Buy rating from Argus with a $190 target, raising que...
CoreWeave has surged into the AI infrastructure spotlight, but the ride is not risk-free. This article analyzes the g...
The Trade Desk declines sharply after softer first-quarter results and a cautious outlook, while AppLovin climbs on s...
Keel Infrastructure led the session with a notable move as investors weighed its pivot to AI data centers. This piece...
SunPower's Q1 2026 results could set the tone for the year. This guide explains what to watch, which numbers matter, ...
Barclays lowers Carvana's price target to $93 after a 5-for-1 stock split, while reaffirming an overweight stance as ...
Nvidia CEO Jensen Huang describes a 1,000% surge in AI compute for agentic AI, triggering a broad rethink of data cen...